Maxim Group Upgrades Coherus Biosciences (CHRS) to Buy, PT $4
Tweet Send to a Friend
(Updated - September 4, 2025 7:57 AM EDT)
Maxim Group analyst Jason McCarthy upgraded Coherus Biosciences (NASDAQ: CHRS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Maxim Group analyst Jason McCarthy upgraded Coherus Biosciences (NASDAQ: CHRS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
